{
    "clinical_study": {
        "@rank": "47173", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die. Giving chemotherapy drugs before surgery may shrink the tumor\n      so that it can be removed during surgery.\n\n      PURPOSE: Phase III trial to determine the effectiveness of combination chemotherapy given\n      before surgery in treating children who have localized neuroblastoma."
        }, 
        "brief_title": "Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": "Neuroblastoma", 
        "condition_browse": {
            "mesh_term": "Neuroblastoma"
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Determine the outcome, in terms of local control, event-free survival, and overall\n           survival, of children with localized unresectable neuroblastoma without MYCN\n           amplification treated with carboplatin, etoposide, cyclophosphamide, doxorubicin, and\n           vincristine followed by surgery.\n\n      OUTLINE: This is a multicenter study.\n\n      Patients receive carboplatin IV over 1 hour and etoposide IV over 2 hours on days 1-3\n      (courses 1 and 3). Patients receive cyclophosphamide IV over 1 hour on days 1-5 (or orally\n      on days 2 and 3), doxorubicin IV over 6 hours on days 4-5, and vincristine IV on days 1 and\n      5 (courses 2 and 4). Treatment repeats every 21 days for 4 courses. Patients then undergo\n      surgical resection followed by 2 additional courses of chemotherapy.\n\n      Patients are followed at months 8, 10, 12, 16, 20, 24, 30, 36, 42, 48, and 60.\n\n      PROJECTED ACCRUAL: A total of 100 patients will be accrued for this study within 4 years."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Diagnosis of localized unresectable neuroblastoma\n\n               -  Stage II or III\n\n               -  No MYCN amplification\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  Over 1\n\n        Performance status:\n\n          -  Not specified\n\n        Life expectancy:\n\n          -  Not specified\n\n        Hematopoietic:\n\n          -  Not specified\n\n        Hepatic:\n\n          -  Not specified\n\n        Renal:\n\n          -  Not specified\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  Not specified\n\n        Chemotherapy:\n\n          -  No prior chemotherapy\n\n        Endocrine therapy:\n\n          -  Not specified\n\n        Radiotherapy:\n\n          -  No prior radiotherapy\n\n        Surgery:\n\n          -  Not specified"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 11, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00025428", 
            "org_study_id": "CDR0000068960", 
            "secondary_id": [
                "SIOP-NB-2009", 
                "CCLG-NB-2000-09", 
                "EU-20107"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "carboplatin", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "cyclophosphamide", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "doxorubicin hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "etoposide", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "vincristine sulfate", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "adjuvant therapy", 
                "intervention_type": "Procedure"
            }, 
            {
                "intervention_name": "conventional surgery", 
                "intervention_type": "Procedure"
            }, 
            {
                "intervention_name": "neoadjuvant therapy", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cyclophosphamide", 
                "Doxorubicin", 
                "Etoposide", 
                "Vincristine", 
                "Carboplatin"
            ]
        }, 
        "keyword": "localized unresectable neuroblastoma", 
        "lastchanged_date": "December 3, 2013", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/SIOP-NB-2009"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Vienna", 
                        "country": "Austria", 
                        "zip": "A-1090"
                    }, 
                    "name": "St. Anna Children's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ghent", 
                        "country": "Belgium", 
                        "zip": "B-9000"
                    }, 
                    "name": "Universitair Ziekenhuis Gent"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Odense", 
                        "country": "Denmark", 
                        "zip": "DK-5000"
                    }, 
                    "name": "Odense University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "zip": "31026"
                    }, 
                    "name": "Centre Hospitalier Regional de Purpan"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cologne", 
                        "country": "Germany", 
                        "zip": "D-50924"
                    }, 
                    "name": "Children's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Genoa", 
                        "country": "Italy", 
                        "zip": "16148"
                    }, 
                    "name": "Istituto Giannina Gaslini"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oslo", 
                        "country": "Norway", 
                        "zip": "0027"
                    }, 
                    "name": "Rikshospitalet University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lisboa", 
                        "country": "Portugal", 
                        "zip": "1099-023 Codex"
                    }, 
                    "name": "Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, S.A."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain", 
                        "zip": "46009"
                    }, 
                    "name": "Hospital Universitario LA FE"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gothenburg", 
                        "country": "Sweden", 
                        "zip": "41685"
                    }, 
                    "name": "Ostra Sjukhuset"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lausanne", 
                        "country": "Switzerland", 
                        "zip": "CH-1011"
                    }, 
                    "name": "Centre Hospitalier Universitaire Vaudois"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Southampton", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "SO16 6YD"
                    }, 
                    "name": "Southampton University Hospital NHS Trust"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Austria", 
                "Belgium", 
                "Denmark", 
                "France", 
                "Germany", 
                "Italy", 
                "Norway", 
                "Portugal", 
                "Spain", 
                "Sweden", 
                "Switzerland", 
                "United Kingdom"
            ]
        }, 
        "official_title": "Treatment Of Children Over The Age Of 1 Year With Unresectable Localized Neuroblastoma Without MYCN Amplification", 
        "overall_official": {
            "affiliation": "University Hospital Southampton NHS Foundation Trust.", 
            "last_name": "Janice A. Kohler, MD, FRCP", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 3", 
        "primary_outcome": {
            "measure": "Event-free survival at 3 years", 
            "safety_issue": "No"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00025428"
        }, 
        "source": "National Cancer Institute (NCI)", 
        "sponsors": {
            "collaborator": {
                "agency": "Children's Cancer and Leukaemia Group", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Societe Internationale d'Oncologie Pediatrique", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2000", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2006"
    }, 
    "geocoordinates": {
        "Centre Hospitalier Regional de Purpan": "43.605 1.444", 
        "Centre Hospitalier Universitaire Vaudois": "46.52 6.634", 
        "Children's Hospital": "50.958 6.92", 
        "Hospital Universitario LA FE": "39.47 -0.377", 
        "Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, S.A.": "38.707 -9.136", 
        "Istituto Giannina Gaslini": "44.407 8.934", 
        "Odense University Hospital": "55.404 10.402", 
        "Ostra Sjukhuset": "57.709 11.975", 
        "Rikshospitalet University Hospital": "59.914 10.752", 
        "Southampton University Hospital NHS Trust": "50.91 -1.404", 
        "St. Anna Children's Hospital": "48.208 16.374", 
        "Universitair Ziekenhuis Gent": "51.053 3.73"
    }
}